Elevance Health Long-term marketable securities decreased by 0.6% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from $1.06B to $1.11B. Over 5 years (FY 2020 to FY 2025), Long-term marketable securities shows an upward trend with a 14.8% CAGR.
An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.
This represents long-term investments in debt securities that the company intends to hold for more than one year. These...
Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.
non_current_assets_available_for_sale_securities_debt_se_908f76| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $581.00M | $625.00M | $632.00M | $596.00M | $603.00M | $622.00M | $752.00M | $783.00M | $775.00M | $816.00M | $876.00M | $880.00M | $849.00M | $893.00M | $1.04B | $1.06B | $1.09B | $1.11B | $1.12B | $1.11B |
| QoQ Change | — | +7.6% | +1.1% | -5.7% | +1.2% | +3.2% | +20.9% | +4.1% | -1.0% | +5.3% | +7.4% | +0.5% | -3.5% | +5.2% | +15.9% | +2.4% | +2.5% | +2.2% | +0.9% | -0.6% |
| YoY Change | — | — | — | — | +3.8% | -0.5% | +19.0% | +31.4% | +28.5% | +31.2% | +16.5% | +12.4% | +9.5% | +9.4% | +18.2% | +20.5% | +28.0% | +24.4% | +8.3% | +5.1% |